TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL

Belinda A Di Bartolo1, Siân P Cartland, Hanis H Harith

  • 1Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia.

Plos One
|September 17, 2013
PubMed

Insights

TNF-related apoptosis-inducing ligand (TRAIL) deficiency accelerates vascular calcification and cartilaginous metaplasia in atherosclerosis. TRAIL regulates receptor activator of nuclear factor-κB ligand (RANKL) and inflammatory markers involved in vascular bone turnover.

Area of Science:

  • Vascular Biology
  • Bone Homeostasis
  • Atherosclerosis Research

Background:

  • The osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) system regulates bone homeostasis and vascular calcification.
  • TNF-related apoptosis-inducing ligand (TRAIL) is a second OPG ligand with an unestablished role in vivo vascular calcification.

Purpose of the Study:

  • To investigate the role of TRAIL in vascular calcification in vitro and in vivo.
  • To examine the involvement of OPG and RANKL in TRAIL-mediated vascular calcification.

Main Methods:

  • In vitro studies used vascular smooth muscle cells (VSMCs) from TRAIL(-/-) and wild-type mice.
  • In vivo studies utilized TRAIL(-/-)ApoE(-/-) mice with advanced atherosclerotic lesions.
  • Analysis included calcium-induced calcification, gene expression (RANKL, OPG, TRAIL, collagen II, BMP-2, IL-1β, PPAR-γ), and histological assessment.

Main Results:

  • TRAIL inhibited calcium-induced calcification in human VSMCs; TRAIL(-/-) VSMCs showed accelerated calcification.
  • TRAIL deficiency in mice led to increased chondrocyte-like cells, collagen II, RANKL, BMP-2, IL-1β, and PPAR-γ expression in atherosclerotic lesions.
  • Significant increases in vascular calcification were observed in TRAIL(-/-)ApoE(-/-) mice.

Conclusions:

  • TRAIL deficiency accelerates cartilaginous metaplasia and vascular calcification in atherosclerosis.
  • TRAIL plays a crucial role in regulating RANKL and inflammatory mediators of vascular bone turnover.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...